Top 5 High Return Indian Stocks in July 2025

simran

Glenmark Pharmaceuticals: +32% in July after $2 bn cancer‑drug licensing deal with AbbVie

Bosch: +18% gain, boosted by auto‑sector uptrend and Q1 FY26 momentum

Vodafone Idea: +17% on 5G rollout across cities and infrastructure upgrades

Motilal Oswal Fin. Services: +14%, AMU crosses ₹1.5 lakh cr milestone

Paytm (One97): +14%, investor optimism ahead of Q1 FY26 earnings

Read More Stories